FORM 6-K
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Report of Foreign Issuer
Pursuant to Rule 13a-16 or 15d-16 of
the Securities Exchange Act of 1934
For the month of October, 2026
Commission File Number: 001-12518
Banco Santander, S.A.
(Exact name of registrant as specified in its charter)
Ciudad Grupo Santander
28660 Boadilla del Monte (Madrid) Spain
(Address of principal executive office)
As filed with the Securities and Exchange Commission on October 21, 2026
Registration No. 333-297771
UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON, D.C. 20549
_______________________
AMENDMENT NO. 4 TOFORM S-1REGISTRATION STATEMENTUNDERTHE SECURITIES ACT OF 1933
_______________________
PBT Land and Minerals, Inc.(Exact name of registrant as specified in its charter)
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16 OR 15D-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
October, 2026
Commission File Number 1-15182
DR. REDDY’S LABORATORIES LIMITED
(Translation of registrant’s name into English)
8-2-337, Road No. 3, Banjara Hills
Hyderabad, Telangana 500 034, India
+91-40-49002900
(Address of principal executive office)
Indicate by check mark whether the registrant... (continue reading...)
http://archive.fast-edgar.com/20261021/AC22G22DLC22J282222Q2CY2BS8FC222E282
Filed on: October 21, 2026
Filed by Cadeler plc
Pursuant to Rule 425 under the Securities Act of 1933, as amended
and deemed filed pursuant to Rule 14d-2 of the Securities Exchange Act of 1934, as amended
Subject Company: Cadeler A/S (Commission File No.: 001-41889)
Registration Statement File No.: 333-298599
THIS ANNOUNCEMENT IS NOT A PROSPECTUS AND DOES NOT CONSTITUTE AN OFFER TO PURCHASE, OR A SOLICITATION OF AN OFFER TO SELL, ANY SECURITIES. THE OFFER IS MADE IN THE EU/EEA... (continue reading...)
More SEC Filings
View Older Stories-
Form 6-K PRUDENTIAL PLC For: Oct 21
-
Form 8-K INTEGRA LIFESCIENCES For: Oct 21
-
Form 13F-HR Capstone Capital Managem For: Sep 30
-
Form 6-K GSK plc For: Oct 21
-
Form 13F-NT/A Hang Seng Investment For: Sep 30
-
Form 13F-HR/A Lancaster Investment For: Sep 30
-
Form DEFA14A reAlpha Tech Corp.
-
Form 6-K Guardian Metal Resources For: Oct 21
-
Form 425 Silicon Valley Acquisiti Filed by: EigenQ Inc
-
Form 6-K Innate Pharma SA For: Oct 21
-
Form 425 Silicon Valley Acquisiti Filed by: Silicon Valley Acquisition Corp.
-
Form 6-K Cadeler A/S For: Oct 21
-
Form 6-K Vertical Aerospace Ltd. For: Oct 21
-
Form 4/A EXOZYMES INC. For: Aug 19 Filed by: Korman Tyler Paz
-
Form 6-K CHIPMOS TECHNOLOGIES For: Oct 21
-
Form C SalesFaucet, Inc.
-
Form C Tarpestry Co. LLC
-
Form 8-K Silicon Valley Acquisiti For: Oct 19
-
Form EFFECT Dermata Therapeutics,
-
Form EFFECT SKYX Platforms Corp.
-
Form EFFECT Klabin S.A./ADR
-
Form S-6/A Advisors Disciplined
-
Form EFFECT Andean Silver Ltd
-
Form EFFECT GT Biopharma, Inc.
-
Form DEFA14A XWELL, Inc.
-
Form 6-K ALTERITY THERAPEUTICS For: Oct 31
-
Form 8-K THERMO FISHER SCIENTIFIC For: Oct 21
-
Form 8-K reAlpha Tech Corp. For: Oct 21
-
Form 6-K SHINHAN FINANCIAL GROUP For: Oct 21
-
Form 6-K KB Financial Group Inc. For: Oct 21
-
Form 4 Sea Ltd For: Oct 19 Filed by: Wang Yanjun
-
Form 6-K HUTCHMED (China) Ltd For: Oct 21
-
Form 6-K Lufax Holding Ltd For: Oct 21
-
Form 8-K Artificial Intelligence For: Oct 21
-
Form 8-K Nuburu, Inc. For: Oct 15
-
Form 6-K JinkoSolar Holding Co., For: Oct 21
-
Form 6-K SHINHAN FINANCIAL GROUP For: Oct 21
-
Form EFFECT EQUITY BANCSHARES INC
-
Form 6-K Lichen International For: Oct 21
-
Form S-4/A STANDARD BIOTOOLS INC.
-
Form EFFECT HMH Holding Inc
-
Form 6-K ALTERITY THERAPEUTICS For: Oct 31
-
Form 4 Sea Ltd For: Oct 19 Filed by: Hou Tianyu
-
Form EFFECT APPLIED ENERGETICS, INC.
-
Form 8-K Elevance Health, Inc. For: Oct 21
-
Form D DPEG SPAC, LP
-
Form 6-K Guardian Metal Resources For: Oct 21
-
Form 6-K WOODSIDE ENERGY GROUP For: Oct 21
-
Form 13F-HR Luma Capital S.A. - SPF For: Sep 30
-
Form 8-K ENTRAVISION COMMUNICATIO For: Oct 19
